Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism

Klein, 1981, New perspectives on thyroid hormone catecholamines and the heart, Am J Med, 76, 167, 10.1016/0002-9343(84)90768-X Degroot, 1972, Thyroid and the heart, Mayo Clin Proc, 47, 864 Morkin, 1983, Biochemical and physiologic effects of thyroid hormone on cardiac performance, Prog Cardiovasc Dis, 25, 435, 10.1016/0033-0620(83)90004-X Waldstein, 1966, Thyroid-catecholamine interrelations, Annu Rev Med, 17, 123, 10.1146/annurev.me.17.020166.001011 Levey, 1971, Catecholamine sensitivity, thyroid hormone and the heart, Am J Med, 50, 413, 10.1016/0002-9343(71)90331-7 Harrison, 1964, Adrenal medullary and thyroid relationships, Physiol Rev, 44, 161, 10.1152/physrev.1964.44.2.161 Landsberg, 1977, Catecholamines and hyperthyroidism, Clin Endocrinol Metab, 6, 697, 10.1016/S0300-595X(77)80076-5 Grossman, 1971, The enhanced myocardial contractility of thyrotoxicosis, Ann Intern Med, 74, 869, 10.7326/0003-4819-74-6-869 Levey, 1976, The adrenergic nervous system in hyperthyroidism: therapeutic role of beta adrenergic blocking drugs, Pharmacol Ther, 1, 431 Liggett, 1989, Increased fat and skeletal muscle B-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis, J Clin Invest, 83, 803, 10.1172/JCI113961 Klein, 1989, Thyroid hormone and high blood pressure, Volume 2, 61 Manger, 1989, A clinical and experimental overview of pheochromocytoma, Volume 2, 19 Goldman, 1981, Beta-adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance, J Pharmacol Exp Ther, 219, 394 Vinik, 1968, Sympathetic nervous system blocking in hyperthyroidism, Endocrinology, 28, 725 Weiner, 1969, Influence of beta sympathetic blockade (propranolol) on the hemodynamics of hyperthyroidism, Am J Med, 46, 227, 10.1016/0002-9343(69)90007-2 Goetsch, 1918, Adrenaline hypersensitiveness in clinical states of hyperthyroidism, NY State J Med, 259 Rosenblum, 1933, Epinephrine: its effect on the cardiac mechanism in experimental hyperthyroidism and hypothyroidism, Arch Intern Med, 51, 279, 10.1001/archinte.1933.00150210109008 Buccino, 1967, Influence of thyroid state on the intrinsic contractile properties and energy stores of the myocardium, J Clin Invest, 46, 1669, 10.1172/JCI105658 Sanford, 1978, Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats, Circ Res, 43, 688, 10.1161/01.RES.43.5.688 Klein, 1986, Effects of thyroid hormone on the myosin content and myosin isoenzymes of the heterotopically transplanted heart, J Clin Invest, 77, 1694, 10.1172/JCI112488 Trzepacz, 1989, Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms, Am J Med, 87, 558, 10.1016/S0002-9343(89)80614-X Thomas, 1970, Apathetic thyrotoxicosis: a distinct clinical and laboratory entity, Ann Intern Med, 72, 679, 10.7326/0003-4819-72-5-679 Forfar, 1985, Hyperthyroid heart disease, Clin Endocrinol Metab, 14, 491, 10.1016/S0300-595X(85)80044-X Bilezikian, 1983, The influence of hyperthyroidism and hypothyroidism on α- and β-adrenergic receptor systems and adrenergic responsiveness, Endocr Rev, 4, 378, 10.1210/edrv-4-4-378 Trzepacz, 1988, Psychiatric and neuropsychological response to propranolol in Graves' disease, Biol Psychiatry, 23, 678, 10.1016/0006-3223(88)90051-0 Klein, 1988, Symptom rating scale for assessing hyperthyroidism, Arch Intern Med, 148, 387, 10.1001/archinte.1988.00380020131018 Watanakunakorn, 1965, Myxedema—a study of 400 cases, Arch Intern Med, 116, 183, 10.1001/archinte.1965.03870020023008 Klein, 1984, Unusual manifestations of hypothyroidism, Arch Intern Med, 144, 123, 10.1001/archinte.1984.00350130143025 Dillman, 1985, Mechanisms of action of thyroid hormones, Med Clin North Am, 69, 849, 10.1016/S0025-7125(16)30993-2 Coulombe, 1976, Catecholamine metabolism in thyroid diseases. I. Epinephrine secretion rate in hyperthyroidism and hypothyroidism, J Clin Endocrinol Metab, 42, 125, 10.1210/jcem-42-1-125 Coulombe, 1976, Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism, Metabolism, 25, 973, 10.1016/0026-0495(76)90126-8 Bayliss, 1971, Urinary excretion of free catecholamines in Graves' disease, Endocrinology, 49, 167, 10.1677/joe.0.0490167 Beaven, 1963, The turnover of norepinephrine in thyrotoxic and nonthyrotoxic mice, Life Sci, 4, 241, 10.1016/0024-3205(63)90004-3 Dratman, 1982, Nervous system role of iodocompounds in blood pressure regulation, Life Sci, 30, 611, 10.1016/0024-3205(82)90277-6 Dratman, 1976, Thyroid function and high blood pressure, Cardiovasc Med, 1, 319 Williams, 1977, Thyroid hormone regulation of β-adrenergic number, J Biol Chem, 252, 2787, 10.1016/S0021-9258(17)40528-X Ginsberg, 1981, Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte β-adrenergic receptor density in man, J Clin Invest, 67, 1785, 10.1172/JCI110218 Sutherland, 1968, Some aspects of the biological role of adenosine 3′5′-monophosphate, Circulation, 37, 279, 10.1161/01.CIR.37.2.279 Ransnas, 1988, Increased Gs in myocardial membranes from hyperthyroid pigs, Clin Res, 36, 552A Arnsdorf, 1970, Atrial electrophysiology in experimental hyperthyroidism in rabbits, Circ Res, 26, 575, 10.1161/01.RES.26.5.575 Polikar, 1989, Norepinephrine plasma kinetics in hypothyroid patients before and following replacement therapy, Circ Res, 37, 362A Surawicz, 1985, Factors affecting tolerance to digitalis, J Am Coll Cardiol, 5, 69A, 10.1016/S0735-1097(85)80465-4 Coulombe, 1977, Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism, J Clin Endocrinol Metab, 44, 1185, 10.1210/jcem-44-6-1185 Braverman, 1978, Therapeutic considerations, Clin Endocrinol Metab, 7, 221, 10.1016/S0300-595X(78)80044-9 Canary, 1957, Effects of oral and intramuscular administration of reserpine in thyrotoxicosis, N Engl J Med, 257, 435, 10.1056/NEJM195709052571001 Turner, 1965, Effect of adrenergic receptor blockade on the tachycardia of thyrotoxicosis and anxiety state, Lancet, 2, 1316, 10.1016/S0140-6736(65)92340-8 Wilkinson, 1984, A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis, Am Heart J, 108, 1160, 10.1016/0002-8703(84)90601-X Murchison, 1979, Comparison of propranolol and metoprolol in the management of hyperthyroidism, Br J Clin Pharmacol, 8, 581, 10.1111/j.1365-2125.1979.tb01048.x Klein, 1984, Thyroid emergencies: thyroid storm and myxedema coma, Top Emerg Med, 5, 33 Cooper, 1982, Hyperthyroxinemia in patients treated with high-dose propranolol, Am J Med, 73, 867, 10.1016/0002-9343(82)90778-1 Mazzaferri, 1976, Propranolol as primary therapy for thyrotoxicosis, Arch Intern Med, 136, 50, 10.1001/archinte.1976.03630010034006 McDermott, 1978, Comparative trial of atenolol and propranolol in hyperthyroidism, Br J Clin Pharmacol, 6, 233, 10.1111/j.1365-2125.1978.tb04590.x Roti, 1988, The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients, Arch Intern Med, 148, 1919, 10.1001/archinte.1988.00380090021007 Gallery, 1985, Hypertension in pregnant women, Med J Aust, 143, 23, 10.5694/j.1326-5377.1985.tb119918.x